Search Results 291-300 of 1132 for 구글찌라시 を 16242242 を텔@adtopkingをを구글상위ををを텔@adtopkingをををSEO키워드ををを

  1. Cardiovascular Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH - Mayo Clinic

    Cohort 2 will enroll approximately 400 subjects with a clinical diagnosis of compensated cirrhosis due to NASH/MASH. Evaluation of the clinical outcomes primary ...

  3. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Study of Safety of Foradil in Patients with Persistent Asthma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

    About this study. The primary purpose of this study is to describe the utilization and findings on magnetic resonance imaging (MRI) of the hands and feet in ...

  6. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    This study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI). Enrolled subjects ...

  7. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...

  8. A Study of New Laboratory Assays to Develop Better Therapies for Treating Patients with Graves’ Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    The purpose of this study, is to open expanded access at specific clinical sites at the request of an investigator for the treatment of individual subjects for ...

  10. Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) - Mayo Clinic

    The purpose of this study is to assess the clinical benefit of Nivolumab, as measured by independent radiologic review committee (IRRC)-assessed objective ...